Analyst Ratings for Myriad Genetics Inc. (MYGN)

Updated: 2017-07-26

An average rating of Hold has been given to Myriad Genetics Inc. (NASDAQ:MYGN) by analysts covering the stock. MYGN had previously received a consensus rating of Hold a month ago.

15 analysts issued ratings on the stock, where 2 gave MYGN a buy rating, 0 issued an overweight rating, 9 gave a hold rating, 1 gave an underweight rating, and 3 gave a sell rating. Today, there are 0 more analysts optimistic about the company future as compared with 90 days ago. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Many analysts weighed in on price targets for MYGN. The maximum price target given was 30, implying a possible profit of 26.37 percent. The most pessimistic analyst gave a price target of 16, which equates to a potential downside of -32.6 percent. It is advisable to not rely only on price targets or ratings, as these can be biased for some stocks.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -1.65 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 3.56 percent.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, which can be compared to the 0 analysts that decreased their estimates. During this time, 2 analysts made positive revisions in their estimates for this fiscal year's earnings, while 0 analysts made negative revisions to their fiscal year's estimates.

MYGN has an estimated earnings growth rate of 135.64 percent as forecasted by analysts. Another measure frequently examined by investors is the PEG ratio. A lower PEG ratio is favorable, as that can indicate whether the high price level of a stock is warranted by high growth. People often look for the PEG ratio to be under 1, even though it may be more relevant to compare the ratio to that of a firm's competitors. MYGN has a PEG ratio of 0.39.

MYGN has a 52-week high of 32.54 and a 52-week low of 15.15. Currently the stock is 56.7 percent higher than its low, and 27.04 percent lower than its 52-week high. MYGN has a price/earnings ratio of 52.76. Investors typically compare the P/E ratio to a company's peers in the industry. The MYGN value stock report compares MYGN to some of its peers using value stock charts. The market cap of MYGN is $1.63 billion. MYGN will post this quarters earnings in days, on 0000-00-00.